Bellicum Pharmaceuticals Inc (BLCM) Insider Trading
- $2,125,232.00
- $18,581,734.69
- Sept. 10, 2019
- Kevin M Slawin
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 10, 2019 | CEO | 40,000 | $1.25 | Buy | $50,000.00 | |
Aug. 29, 2019 | VP | 8,000 | $1.23 | Buy | $9,840.00 | |
Aug. 21, 2019 | CEO | 20,000 | $0.99 | Buy | $19,800.00 | |
Nov. 9, 2018 | Director | 10,000 | $4.56 | Buy | $45,600.00 | |
Sept. 4, 2018 | CTO | 10,000 | $7.04 | Sell | $70,400.00 | |
July 18, 2018 | Insider | 40,000 | $7.63 | Sell | $305,200.00 | |
May 25, 2018 | CFO | 6,206 | $7.97 | Sell | $49,461.82 | |
Jan. 19, 2018 | Major Shareholder | 880,735 | $8.20 | Sell | $7,222,027.00 | |
Jan. 17, 2018 | Major Shareholder | 260,600 | $8.63 | Sell | $2,248,978.00 | |
Jan. 9, 2018 | EVP | 487 | $9.40 | Sell | $4,577.80 | |
Dec. 11, 2017 | CFO | 17,117 | $9.33 | Sell | $159,701.61 | |
Nov. 27, 2017 | CFO | 6,206 | $9.89 | Sell | $61,377.34 | |
July 24, 2017 | EVP | 437 | $11.85 | Sell | $5,178.45 | |
July 13, 2017 | VP | 13,823 | $12.26 | Sell | $169,469.98 | |
July 10, 2017 | Insider | 10,000 | $11.54 | Sell | $115,400.00 | |
May 25, 2017 | CFO | 6,311 | $12.24 | Sell | $77,246.64 | |
March 24, 2017 | Major Shareholder | 166,666 | $12.00 | Buy | $1,999,992.00 | |
Feb. 7, 2017 | Director | 30,000 | $12.54 | Sell | $376,200.00 | |
Dec. 15, 2016 | Insider | 30,000 | $15.45 | Sell | $463,500.00 | |
Dec. 5, 2016 | Insider | 5,000 | $20.00 | Sell | $100,000.00 | |
Dec. 1, 2016 | COO | 25,000 | $17.54 | Sell | $438,500.00 | |
Nov. 28, 2016 | CFO | 29,300 | $19.51 | Sell | $571,643.00 | |
Sept. 23, 2016 | VP | 11,800 | $20.10 | Sell | $237,180.00 | |
Sept. 23, 2016 | Insider | 23,416 | $20.12 | Sell | $471,129.92 | |
Sept. 20, 2016 | Insider | 2,500 | $20.01 | Sell | $50,025.00 | |
Sept. 20, 2016 | VP | 2,200 | $20.01 | Sell | $44,022.00 | |
Aug. 15, 2016 | VP | 1,000 | $20.00 | Sell | $20,000.00 | |
Aug. 15, 2016 | Insider | 67,000 | $19.31 | Sell | $1,293,770.00 | |
July 27, 2016 | Insider | 10,000 | $15.00 | Sell | $150,000.00 | |
July 18, 2016 | CTO | 2,719 | $13.99 | Sell | $38,038.81 | |
July 15, 2016 | CTO | 22,281 | $13.72 | Sell | $305,695.32 | |
June 2, 2016 | COO | 25,000 | $13.00 | Sell | $325,000.00 | |
June 2, 2016 | VP | 15,000 | $13.00 | Sell | $195,000.00 | |
April 22, 2016 | CTO | 55,000 | $11.43 | Sell | $628,650.00 | |
Jan. 4, 2016 | COO | 35,000 | $19.07 | Sell | $667,450.00 | |
Dec. 1, 2015 | Insider | 5,000 | $22.95 | Sell | $114,750.00 | |
Nov. 24, 2015 | CFO | 29,300 | $22.34 | Sell | $654,562.00 | |
Nov. 2, 2015 | VP | 15,000 | $13.00 | Sell | $195,000.00 | |
Oct. 1, 2015 | CEO | 2,500 | $14.58 | Sell | $36,450.00 | |
Sept. 11, 2015 | Insider | 5,000 | $19.00 | Sell | $95,000.00 | |
Sept. 1, 2015 | CEO | 2,500 | $16.78 | Sell | $41,950.00 | |
July 15, 2015 | CTO | 6,000 | $20.00 | Sell | $120,000.00 | |
June 16, 2015 | Insider | 20,000 | $22.96 | Sell | $459,200.00 |
Insiders are both buying and selling Bellicum Pharmaceuticals Inc stock.
The insider traders at Bellicum Pharmaceuticals Inc are: Kevin M Slawin, David M Spencer, Ken Moseley, Alan A Musso, Annemarie Moseley, Bros. Advisors Lp Baker, Thomas J Farrell, Alan A. Musso, David M. Spencer, Jon P Stonehouse, Alan K. Smith, Richard A Fair, Richard A. Fair, Shane Ward, and Alan K Smith
The most active insider trader at Bellicum Pharmaceuticals Inc is Kevin M Slawin with 8 trades.
Bros. Advisors Lp Baker has sold the most Bellicum Pharmaceuticals Inc stock with a total value of $16,693,032.00.
Bros. Advisors Lp Baker has bought the most Bellicum Pharmaceuticals Inc stock with a total value of $3,999,984.00.
The most recent insider trade for Bellicum Pharmaceuticals Inc was on Sept. 10, 2019.
The single biggest insider buy for Bellicum Pharmaceuticals Inc was from Bros. Advisors Lp Baker with a total value of $1,999,992.00 on March 24, 2017.
The single biggest insider sell for Bellicum Pharmaceuticals Inc was from Bros. Advisors Lp Baker with a total value of $7,222,027.00 on Jan. 19, 2018.